SHUKRA PHARMACEUTICALS
|
The Current P/E Ratio of SHUKRA PHARMACEUTICALS is 45.56.
| Share Price | ₹30.3 | Mar 30,2026 |
| Market Cap | ₹1,328.6 Cr | |
| Earnings-TTM | ₹29.2 Cr | TTM-Standalone Results |
| Price/Earnings | 45.56x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SHUKRA PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,328.6 Cr] as on Mar 30,2026
(/) Earnings [ ₹29.2 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 45.56x ]
Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay 45.56 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHUKRA PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SHUKRA PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of SHUKRA PHARMACEUTICALS
PE Ratio Performance Analysis for SHUKRA PHARMACEUTICALS
- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 22.35x.
- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 2.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 99.91x.
- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0.48x.
How does SHUKRA PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SHUKRA PHARMACEUTICALS | 29.16 | 45.56 | 1,328.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 38.33 | 421,647.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 63.68 | 157,862.0 |
| CIPLA LTD | 4,544.70 | 21.74 | 98,795.9 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 62.87 | 142,846.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.01 | 104,720.0 |
| MANKIND PHARMA LTD | 1,796.65 | 46.09 | 82,807.2 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 17.77 | 87,663.1 |
| LUPIN LTD | 4,669.18 | 22.64 | 105,732.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 21.54 | 75,690.1 |
| ABBOTT INDIA LTD | 1,524.13 | 36.14 | 55,084.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHUKRA PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.77x |
| Max industry PE | 63.68x |
| Median industry PE | 36.14x |
| Average industry PE | 35.94x |
You may also like the below Video Courses